Indigenous COVID-19 vaccine put into use in city

06/02 .2021

Indigenous COVID-19 vaccine put into use in city

AN inactivated COVID-19 vaccine produced by a Shenzhen company was put into use for the general public in the city yesterday, becoming the fourth Chinese-made COVID-19 vaccine to be administered in the city.
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

06/23 .2021

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

08/02 .2021

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
Shenzhen Kangtai says vaccine effective against Delta variant

08/04 .2021

Shenzhen Kangtai says vaccine effective against Delta variant

Shenzhen Kangtai says vaccine effective against Delta variant
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing

09/06 .2021

Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing

Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia

11/03 .2021

BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia

BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
< 1234 >